Charles River Laboratories International, Inc. (CRL) Earnings History
Annual and quarterly earnings data from 1998 to 2025
Loading earnings history...
CRL EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
CRL Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 30.5% | 12.6% | -3.6% |
| 2024 | 32.9% | 5.6% | 0.3% |
| 2023 | 36.4% | 14.9% | 11.5% |
| 2022 | 36.8% | 16.4% | 12.2% |
| 2021 | 37.7% | 16.7% | 11.0% |
Download Data
Export CRL earnings history in CSV or JSON format
Free sign-in required to download data
Charles River Laboratories International, Inc. (CRL) Earnings Overview
As of May 8, 2026, Charles River Laboratories International, Inc. (CRL) reported trailing twelve-month net income of -$185M, reflecting -1555.0% year-over-year growth. The company earned $-3.77 per diluted share over the past four quarters, with a net profit margin of -3.6%.
Looking at the long-term picture, CRL's historical earnings data spans multiple years. The company achieved its highest annual net income of $486M in fiscal 2022.
Charles River Laboratories International, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including IQV ($1.39B net income, 8.3% margin), MEDP ($460M net income, 17.8% margin), ICLR ($599M net income, 9.6% margin), CRL has room to improve margins relative to the peer group. Compare CRL vs IQV →
CRL Earnings vs Peers
Earnings metrics vs comparable public companies
CRL Historical Earnings Data (1998–2025)
28 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$144M | -1501.7% | $508M | $-2.91 | -3.6% | 12.6% |
| 2024 | $10M | -97.8% | $227M | $0.20 | 0.3% | 5.6% |
| 2023 | $475M | -2.4% | $617M | $9.22 | 11.5% | 14.9% |
| 2022 | $486M | +24.4% | $651M | $9.48 | 12.2% | 16.4% |
| 2021 | $391M | +7.3% | $590M | $7.60 | 11.0% | 16.7% |
| 2020 | $364M | +44.6% | $433M | $7.20 | 12.5% | 14.8% |
| 2019 | $252M | +11.3% | $351M | $5.07 | 9.6% | 13.4% |
| 2018 | $226M | +83.5% | $331M | $4.62 | 10.0% | 14.6% |
| 2017 | $123M | -20.3% | $288M | $2.54 | 6.6% | 15.5% |
| 2016 | $155M | +3.7% | $238M | $3.23 | 9.2% | 14.1% |
See CRL's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CRL Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare CRL vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonCRL — Frequently Asked Questions
Quick answers to the most common questions about buying CRL stock.
Is CRL growing earnings?
CRL EPS fell to $-3.77, with earnings declining -1555.0%. This contrasts with the 5-year CAGR of N/A. TTM net income dropped to $-185M.
What are CRL's profit margins?
Charles River Laboratories International, Inc. net margin is -3.6%, with operating margin at +12.6%. Below-average margins reflect competitive or cost pressures.
How consistent are CRL's earnings?
CRL earnings data spans 1998-2025. The declining earnings trend is -1555.0% YoY. Historical data enables comparison across business cycles.